Kura Oncology Inc at Barclays Global Healthcare Conference Transcript
Good afternoon and welcome to Barclays Global Healthcare Conference, do email me and my team if you have questions. And my name is Peter Lawson, and I'm one of the mid-cap biotech analysts at Barclays, cover and focus around oncology companies. Really delighted to have with us on stage Troy Wilson, CEO of Kura Oncology.
Questions & Answers
And I guess with that I'd love to kind of touch upon definitely the menin inhibitor and kind of how we should expect kind of data to unfold, how much more data should we expect to see and I guess that's maybe earmarked for EHA.
First of all Peter, thank you to you and Barclays for the invitation. In terms of the update, we've guided toward midyear, obviously, you have ASCO and EHA, it will be 1 of the 2 -- EHA would be a logical venue just so you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |